ANAPATMOL Research Center, 'Victor Babes' University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania.
Department of Oncology, ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania.
Curr Oncol. 2023 May 8;30(5):4833-4843. doi: 10.3390/curroncol30050364.
Breast cancer is the most frequent neoplasm among women and the second leading cause of death by cancer. It is the most frequent cancer diagnosed during pregnancy. Pregnancy-associated breast cancer is defined as breast cancer that is diagnosed during pregnancy and/or in the postpartum period. Data about young women with metastatic HER2-positive cancer who desire a pregnancy are scarce. The medical attitude in these clinical situations is difficult and nonstandardized. We present the case of a 31-year-old premenopausal woman diagnosed in December 2016 with a stage IV Luminal HER2-positive metastatic breast cancer (pT2 N0 M1 hep). The patient was initially treated by surgery in a conservative manner. Postoperatively, the presence of liver metastases was found by CT investigation. Consequently, line I treatment (docetaxel l75 mg/m² iv; trastuzumab 600 mg/5 mL sq) and ovarian drug suppression (Goserelin 3.6 mg sq at 28 days) was administered. After nine cycles of treatment, the patient's liver metastases had a partial response to the therapy. Despite having a favorable disease evolution and a strong desire to procreate, the patient vehemently refused to continue any oncological treatment. The psychiatric consult highlighted an anxious and depressive reaction for which individual and couple psychotherapy sessions were recommended. After 10 months from the interruption of the oncological treatment, the patient appeared with an evolving pregnancy of 15 weeks. An abdominal ultrasound revealed the presence of multiple liver metastases. Knowing all the possible effects, the patient consciously decided to postpone the proposed second-line treatment. In August 2018, the patient was admitted in the emergency department with malaise, diffuse abdominal pain and hepatic failure. Abdominal ultrasound found a 21-week-old pregnancy which had stopped in evolution, multiple liver metastases and ascites in large quantity. She was transferred to the ICU department where she perished just a few hours later. Conclusions/Discussion: From a psychological standpoint, the patient had an emotional hardship to make the transition from the status of a healthy person to the status of a sick person. Consequently, she entered a process of emotional protection of the positive cognitive distortion type, which favored the decision to abandon treatment and try to complete the pregnancy to the detriment of her own survival. The patient delayed the initiation of oncological treatment in pregnancy until it was too late. The consequence of this delay in treatment led to the death of the mother and fetus. A multidisciplinary team worked to provide this patient with the best medical care and psychological assistance throughout the course of the disease.
乳腺癌是女性最常见的肿瘤,也是癌症死亡的第二大主要原因。它是怀孕期间最常见的诊断出的癌症。与妊娠相关的乳腺癌是指在妊娠期间和/或产后诊断出的乳腺癌。关于希望怀孕的年轻女性转移性 HER2 阳性癌症的数据很少。在这些临床情况下,医疗态度是困难且不标准的。我们介绍了一位 31 岁的绝经前妇女的病例,她于 2016 年 12 月被诊断为四期 Luminal HER2 阳性转移性乳腺癌(pT2 N0 M1 hep)。该患者最初通过手术进行了保守治疗。术后通过 CT 检查发现存在肝转移。因此,给予一线治疗(多西他赛 l75 mg/m² iv;曲妥珠单抗 600 mg/5 mL sq)和卵巢药物抑制(戈舍瑞林 3.6 mg sq 每 28 天)。在进行了九个周期的治疗后,患者的肝转移对治疗有部分反应。尽管疾病进展良好,并且强烈希望生育,但患者强烈拒绝继续任何肿瘤治疗。精神科咨询突出了焦虑和抑郁反应,建议进行个体和夫妻心理治疗。在中断肿瘤治疗 10 个月后,患者出现了 15 周的妊娠。腹部超声显示存在多个肝转移。患者了解所有可能的影响后,有意识地决定推迟拟议的二线治疗。2018 年 8 月,患者因不适、弥漫性腹痛和肝功能衰竭到急诊就诊。腹部超声发现 21 周的妊娠停止发育,多个肝转移和大量腹水。她被转至 ICU 病房,几个小时后去世。结论/讨论:从心理角度来看,患者在从健康人过渡到病人的过程中感到困难。因此,她进入了一种情绪保护的过程,即积极认知扭曲型,这有利于放弃治疗并尝试完成妊娠的决定,而不顾自身的生存。患者在怀孕期间推迟了开始肿瘤治疗的时间,直到为时已晚。这种治疗延迟的后果导致母亲和胎儿死亡。一个多学科团队努力为患者提供最佳的医疗护理和心理援助,贯穿整个疾病过程。